These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22431082)

  • 41. Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study.
    Ragozzino E; Bortolani S; Di Pietro L; Papait A; Parolini O; Monforte M; Tasca G; Ricci E
    Acta Neuropathol Commun; 2023 Oct; 11(1):165. PubMed ID: 37849014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modifications of brain tissue volumes in facioscapulohumeral dystrophy.
    Quarantelli M; Lanzillo R; Del Vecchio W; Mollica C; Prinster A; Iadicicco L; Iodice V; Santoro L; Salvatore M
    Neuroimage; 2006 Sep; 32(3):1237-42. PubMed ID: 16806975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.
    Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E
    Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy.
    Leung DG; Carrino JA; Wagner KR; Jacobs MA
    Muscle Nerve; 2015 Oct; 52(4):512-20. PubMed ID: 25641525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tongue atrophy in facioscapulohumeral muscular dystrophy.
    Yamanaka G; Goto K; Matsumura T; Funakoshi M; Komori T; Hayashi YK; Arahata K
    Neurology; 2001 Aug; 57(4):733-5. PubMed ID: 11524495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of inflammatory lesions over 2 years in facioscapulohumeral muscular dystrophy.
    Dahlqvist JR; Poulsen NS; Østergaard ST; Fornander F; de Stricker Borch J; Danielsen ER; Thomsen C; Vissing J
    Neurology; 2020 Sep; 95(9):e1211-e1221. PubMed ID: 32611642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers.
    Mul K; Horlings CGC; Vincenten SCC; Voermans NC; van Engelen BGM; van Alfen N
    J Neurol; 2018 Nov; 265(11):2646-2655. PubMed ID: 30191320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction.
    Turki A; Hayot M; Carnac G; Pillard F; Passerieux E; Bommart S; Raynaud de Mauverger E; Hugon G; Pincemail J; Pietri S; Lambert K; Belayew A; Vassetzky Y; Juntas Morales R; Mercier J; Laoudj-Chenivesse D
    Free Radic Biol Med; 2012 Sep; 53(5):1068-79. PubMed ID: 22796148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative assessment of skeletal muscle degeneration in patients with myotonic dystrophy type 1 using MRI.
    Hiba B; Richard N; Hébert LJ; Coté C; Nejjari M; Vial C; Bouhour F; Puymirat J; Janier M
    J Magn Reson Imaging; 2012 Mar; 35(3):678-85. PubMed ID: 22069222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Facioscapulohumeral muscular dystrophy.
    Tawil R
    Curr Neurol Neurosci Rep; 2004 Jan; 4(1):51-4. PubMed ID: 14683629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
    Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
    J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Gene diagnosis of facioscapulohumeral muscular dystrophy].
    Zhang JL; Shen DG; Zhou PK; Liu JW; Jia N; Liu H; Wang HB; Yang SX; Frants RR
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):232-4. PubMed ID: 12778451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Teaching NeuroImages: Hemiatrophy as a clinical presentation in facioscapulohumeral muscular dystrophy.
    Sugie K; Hayashi YK; Kin T; Goto K; Nishino I; Ueno S
    Neurology; 2009 Aug; 73(5):e24. PubMed ID: 19652136
    [No Abstract]   [Full Text] [Related]  

  • 54. Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI.
    Olsen DB; Gideon P; Jeppesen TD; Vissing J
    J Neurol; 2006 Nov; 253(11):1437-41. PubMed ID: 16773269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].
    Desnuelle C; Sacconi S; Marolleau JP; Larghero J; Vilquin JT
    Bull Acad Natl Med; 2005 Apr; 189(4):697-713; discussion 713-4. PubMed ID: 16245686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy.
    Reilich P; Schramm N; Schoser B; Schneiderat P; Strigl-Pill N; Müller-Höcker J; Kress W; Ferbert A; Rudnik-Schöneborn S; Noth J; Lochmüller H; Weis J; Walter MC
    J Neurol; 2010 Jul; 257(7):1108-18. PubMed ID: 20146070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior.
    Morosetti R; Gidaro T; Broccolini A; Gliubizzi C; Sancricca C; Tonali PA; Ricci E; Mirabella M
    Cell Transplant; 2011; 20(8):1299-313. PubMed ID: 21176400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No effect of folic acid and methionine supplementation on D4Z4 methylation in patients with facioscapulohumeral muscular dystrophy.
    van der Kooi EL; de Greef JC; Wohlgemuth M; Frants RR; van Asseldonk RJ; Blom HJ; van Engelen BG; van der Maarel SM; Padberg GW
    Neuromuscul Disord; 2006 Nov; 16(11):766-9. PubMed ID: 17005397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy.
    Macaione V; Aguennouz M; Rodolico C; Mazzeo A; Patti A; Cannistraci E; Colantone L; Di Giorgio RM; De Luca G; Vita G
    Acta Neurol Scand; 2007 Feb; 115(2):115-21. PubMed ID: 17212615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Skeletal muscle imaging in facioscapulohumeral muscular dystrophy, pattern and asymmetry of individual muscle involvement.
    Rijken NH; van der Kooi EL; Hendriks JC; van Asseldonk RJ; Padberg GW; Geurts AC; van Engelen BG
    Neuromuscul Disord; 2014 Dec; 24(12):1087-96. PubMed ID: 25176503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.